Zike Yang

492 total citations
12 papers, 419 citations indexed

About

Zike Yang is a scholar working on Oncology, Immunology and Cancer Research. According to data from OpenAlex, Zike Yang has authored 12 papers receiving a total of 419 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 5 papers in Immunology and 4 papers in Cancer Research. Recurrent topics in Zike Yang's work include CAR-T cell therapy research (3 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Hepatocellular Carcinoma Treatment and Prognosis (2 papers). Zike Yang is often cited by papers focused on CAR-T cell therapy research (3 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Hepatocellular Carcinoma Treatment and Prognosis (2 papers). Zike Yang collaborates with scholars based in China and United States. Zike Yang's co-authors include Rongcheng Luo, Mingyu Liu, Shijun Kang, Zehong Chen, Wan Zhang, Jiahe Zhang, Xinyi Wang, Mengxian Tu, Aimin Li and Yue Luo and has published in prestigious journals such as Chemical Engineering Journal, Cancer Science and Journal of Experimental & Clinical Cancer Research.

In The Last Decade

Zike Yang

12 papers receiving 416 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zike Yang China 6 219 130 114 89 46 12 419
Nick A. Kuburich United States 7 260 1.2× 134 1.0× 117 1.0× 51 0.6× 55 1.2× 14 443
Bettina Miller United States 10 230 1.1× 172 1.3× 115 1.0× 72 0.8× 34 0.7× 14 404
Saketh S. Dinavahi United States 11 222 1.0× 136 1.0× 135 1.2× 82 0.9× 42 0.9× 17 409
Renle Du China 13 231 1.1× 140 1.1× 109 1.0× 107 1.2× 53 1.2× 24 429
Lucas Fass United States 3 208 0.9× 126 1.0× 95 0.8× 100 1.1× 55 1.2× 9 446
Marion Richardson France 5 240 1.1× 165 1.3× 142 1.2× 77 0.9× 51 1.1× 7 410
Carolina Hassibe Thomé Brazil 14 308 1.4× 112 0.9× 129 1.1× 67 0.8× 43 0.9× 30 482
Tomas Koltai Italy 10 225 1.0× 198 1.5× 116 1.0× 70 0.8× 50 1.1× 24 456
Xiaohua Jie China 12 300 1.4× 168 1.3× 110 1.0× 128 1.4× 64 1.4× 17 474
Qingwen Jiang United States 2 241 1.1× 163 1.3× 139 1.2× 68 0.8× 64 1.4× 3 452

Countries citing papers authored by Zike Yang

Since Specialization
Citations

This map shows the geographic impact of Zike Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zike Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zike Yang more than expected).

Fields of papers citing papers by Zike Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zike Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zike Yang. The network helps show where Zike Yang may publish in the future.

Co-authorship network of co-authors of Zike Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Zike Yang. A scholar is included among the top collaborators of Zike Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zike Yang. Zike Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Wan-chun, Luo, Jintao Zhang, Zike Yang, et al.. (2025). A ratiometric fluorescence probe based on curcumin and supramolecular deep eutectic solvent for in vivo imaging cerebral pH. Chemical Engineering Journal. 522. 167986–167986. 1 indexed citations
2.
Yang, Zike, Huita Wu, Qing Lin, Xin Wang, & Shijun Kang. (2022). Lymphopenic condition enhanced the antitumor immunity of PD-1-knockout T cells mediated by CRISPR/Cas9 system in malignant melanoma. Immunology Letters. 250. 15–22. 5 indexed citations
3.
Wu, Huita, et al.. (2022). Intravoxel incoherent motion diffusion-weighted imaging for early assessment of combined anti-angiogenic/chemotherapy for colorectal cancer liver metastases. Quantitative Imaging in Medicine and Surgery. 12(9). 4587–4600. 5 indexed citations
4.
5.
Zhang, Wan, Jianpeng Xiao, Xinhui Liu, et al.. (2019). Blocking the PD-1/PD-L1 axis in dendritic cell-stimulated Cytokine-Induced Killer Cells with pembrolizumab enhances their therapeutic effects against hepatocellular carcinoma. Journal of Cancer. 10(11). 2578–2587. 30 indexed citations
6.
Zhou, Jin, Zike Yang, Xiaowen Guo, et al.. (2019). Synthesis and Activity Evaluation of Nasopharyngeal Carcinoma Inhibitors Based on 6‐(Pyrimidin‐4‐yl)‐1H‐indazole. Chemistry & Biodiversity. 16(5). e1800598–e1800598. 3 indexed citations
7.
8.
Liu, Mingyu, et al.. (2018). MCM6 promotes metastasis of hepatocellular carcinoma via MEK/ERK pathway and serves as a novel serum biomarker for early recurrence. Journal of Experimental & Clinical Cancer Research. 37(1). 10–10. 60 indexed citations
9.
Yang, Zike, Jiahe Zhang, Zehong Chen, et al.. (2018). Notch1 signaling in melanoma cells promoted tumor-induced immunosuppression via upregulation of TGF-β1. Journal of Experimental & Clinical Cancer Research. 37(1). 1–1. 258 indexed citations
10.
11.
Zhang, Jiahe, Xinhui Liu, Zike Yang, Yingying Chen, & Rongcheng Luo. (2017). The pretreatment albumin to globulin ratio, a validated biomarker, predicts prognosis in hepatocellular carcinoma.. PubMed. 21(4). 925–934. 16 indexed citations
12.
Yang, Zike, et al.. (2016). Small interfering RNA (siRNA)-mediated knockdown of Notch1 suppresses tumor growth and enhances the effect of IL-2 immunotherapy in malignant melanoma.. PubMed. 20(6). 1553–64. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nick A. Kuburich Breakdown of academic impact, for papers by Bettina Miller Breakdown of academic impact, for papers by Saketh S. Dinavahi Breakdown of academic impact, for papers by Renle Du Breakdown of academic impact, for papers by Lucas Fass Breakdown of academic impact, for papers by Marion Richardson Breakdown of academic impact, for papers by Carolina Hassibe Thomé Breakdown of academic impact, for papers by Tomas Koltai Breakdown of academic impact, for papers by Xiaohua Jie Breakdown of academic impact, for papers by Qingwen Jiang
Rankless by CCL
2026